StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)

Close on Nov 17, 2026Market cap $249.12MP/E –Yield –

Amarin total assets

Total assets on the balance sheet at the end of each period.

Amarin's total assets was $634.08M at Sep 30, 2026. For fiscal 2025 it was $670.78M, down 2.1% from the year before. Over ten years it grew 14.5% a year on average. The highest annual figure on record is $1.07B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$670.78M-2.1%
FY2024Dec 31, 2024$685.35M-17.6%
FY2023Dec 31, 2023$831.68M-6.1%
FY2022Dec 31, 2022$886.18M-17.0%
FY2021Dec 31, 2021$1.07B+10.6%
FY2020Dec 31, 2020$966.02M+9.5%
FY2019Dec 31, 2019$882.21M+128.7%
FY2018Dec 31, 2018$385.71M+138.7%
FY2017Dec 31, 2017$161.60M-3.2%
FY2016Dec 31, 2016$167.00M-3.6%
FY2015Dec 31, 2015$173.23M+1.2%
FY2014Dec 31, 2014$171.11M-32.2%
FY2013Dec 31, 2013$252.48M-18.8%
FY2012Dec 31, 2012$310.86M+146.0%
FY2011Dec 31, 2011$126.38M+257.3%
FY2010Dec 31, 2010$35.37M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$634.08M-3.9%
Q2 FY2026Jun 30, 2026$624.36M-6.8%
Q1 FY2026Mar 31, 2026$645.76M-1.5%
Q4 FY2025Dec 31, 2025$670.78M-2.1%
Q3 FY2025Sep 30, 2025$659.81M-12.1%
Q2 FY2025Jun 30, 2025$670.13M-16.2%
Q1 FY2025Mar 31, 2025$655.68M-17.0%
Q4 FY2024Dec 31, 2024$685.35M-17.6%
Q3 FY2024Sep 30, 2024$750.62M-10.5%
Q2 FY2024Jun 30, 2024$799.86M-7.0%
Q1 FY2024Mar 31, 2024$790.01M-8.2%
Q4 FY2023Dec 31, 2023$831.68M-6.1%
Q3 FY2023Sep 30, 2023$839.03M-7.6%
Q2 FY2023Jun 30, 2023$860.02M-11.6%
Q1 FY2023Mar 31, 2023$860.19M-11.7%
Q4 FY2022Dec 31, 2022$886.18M-17.0%
Q3 FY2022Sep 30, 2022$908.30M-12.3%
Q2 FY2022Jun 30, 2022$973.24M-6.9%
Q1 FY2022Mar 31, 2022$973.71M-1.7%
Q4 FY2021Dec 31, 2021$1.07B+10.6%
Q3 FY2021Sep 30, 2021$1.04B+7.9%
Q2 FY2021Jun 30, 2021$1.04B+14.2%
Q1 FY2021Mar 31, 2021$990.25M+7.0%
Q4 FY2020Dec 31, 2020$966.02M+9.5%
Q3 FY2020Sep 30, 2020$960.20M+10.8%
Q2 FY2020Jun 30, 2020$914.87M+134.6%
Q1 FY2020Mar 31, 2020$925.67M+148.7%
Q4 FY2019Dec 31, 2019$882.21M+128.7%
Q3 FY2019Sep 30, 2019$866.94M+312.3%
Q2 FY2019Jun 30, 2019$389.92M+91.0%
Q1 FY2019Mar 31, 2019$372.24M+72.6%
Q4 FY2018Dec 31, 2018$385.71M+138.7%
Q3 FY2018Sep 30, 2018$210.29M+26.2%
Q2 FY2018Jun 30, 2018$204.13M+19.9%
Q1 FY2018Mar 31, 2018$215.71M+23.1%
Q4 FY2017Dec 31, 2017$161.60M-3.2%
Q3 FY2017Sep 30, 2017$166.61M–
Q2 FY2017Jun 30, 2017$170.19M–
Q1 FY2017Mar 31, 2017$175.20M–
Q4 FY2016Dec 31, 2016$167.00M–

More Amarin figures

See a number that looks wrong?